Biomarker discovery, development, and implementation in France: A report from the French National Cancer Institute and Cooperative Groups

Clinical Cancer Research

Volumn 18, Issue 6, 2012, Pages 1555-1560

  Andre, Fabrice ^a,b   Nowak, Frederique ^c   Arnedos, Monica ^a,b   Lacroix, Ludovic ^a   Viens, Patrice ^a,d   Calvo, Fabien ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNICANCER   (France)

^c INSTITUT NATIONAL DU CANCER   (France)

^d INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; K RAS PROTEIN; PANITUMUMAB; STEM CELL FACTOR RECEPTOR;

BREAST CANCER; CANCER PATIENT; CANCER RESEARCH; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC TEST APPROVAL; DISEASE MARKER; DNA MICROARRAY; FRANCE; FUNDING; GENE EXPRESSION; GENE MUTATION; HEALTH CARE ACCESS; HUMAN; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REIMBURSEMENT; REVIEW; TRANSLATIONAL RESEARCH;

FRANCE; GOVERNMENT PROGRAMS; GOVERNMENT REGULATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; LABORATORIES; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858190933     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-2201     Document Type: Review

References (15)

1. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 2006;100:229-35. (Pubitemid 44631925)
2. Simon RM, Paik S, Hayes DF. Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst 2009;101:1446-52.
3. Andre F, McShane LM, Michiels S, Ransohoff DF, Altman DG, Reis- Filho JS, et al Biomarker studies: a call for a comprehensive biomarker study registry. Nat Rev Clin Oncol 2011;8:171-6.
4. ClinicalTrials.gov [homepage on the Internet]. Available from: http://clinicaltrials.gov/ct2/results?term=NCT01180335.
5. ClinicalTrials.gov [homepage on the Internet]. Available from: http://clinicaltrials.gov/ct2/results?term=NCT01414933.
6. Toussaint J, Sieuwerts AM, Haibe-Kains B, Desmedt C, Rouas G, Harris AL, et al Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues. BMC Genomics 2009;10:424.
7. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-26. (Pubitemid 40051905)
8. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, et al Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817-25.
9. Poste G, Carbone DP, Parkinson DR, Verweij J, Hewitt SM, Jessup JM. Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development. Clin Cancer Res 2012;18:1515-23.
10. Schilsky RL, Doroshow JH, LeBlanc M, Conley BA. Development and use of integral assays in clinical trials. Clin Cancer Res 2012;18:1540-66.
11. Williams PM, Lively TG, Jessup JM, Conley BA. Bridging the gap: moving predictive and prognostic assays from research to clinical use. Clin Cancer Res 2012;18:1531-39.
12. Meshinchi S, Hunger SP, Aplenc R, Adamson PC, Jessup JM. Lessons learned from the Investigational Device Exemption review of Children's Oncology Group Trial AAML1031. Clin Cancer Res 2012;18:1547-54.
13. CIT [homepage on the Internet]. Available from: http://cit.ligue-cancer. net/.
14. Guedj M, Marisa L, de Reynies A, Orsetti B, Schiappa R, Bibeau F, et al A refined molecular taxonomy of breast cancer. Oncogene 2012;31:1196-206.
15. Institut National du Cancer [homepage on the Internet]. French National Cancer Institute Scientific Report 2010-2011. Available from: http://www.e-cancer.fr/component/docman/doc-download/7784-rapport-du-conseil- scientifique-international-2011-version-anglaise.